Research Papers

25 of 75 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Work-related predictors for return to work after stroke.
Palstam A; Westerlind E; Persson HC; Sunnerhagen KS.
Acta Neurol Scand (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk A; Knake S; Kälviäinen R; Santamarina E; Toledo M; Willig S; Rohracher A; Trinka E; Rosenow F.
Acta Neurol Scand (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Structural correlates of cognitive impairment in normal pressure hydrocephalus.
Peterson KA; Mole TB; Keong NCH; DeVito EE; Savulich G; Pickard JD; Sahakian BJ.
Acta Neurol Scand (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Glucose metabolism in the brain in LMNB1-related autosomal dominant leukodystrophy.
Finnsson J; Lubberink M; Savitcheva I; Fällmar D; Melberg A; Kumlien E; Raininko R.
Acta Neurol Scand (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Lacosamide monotherapy in clinical practice: A retrospective chart review.
Villanueva V; Giráldez BG; Toledo M; Toledo M; De Haan GJ; Cumbo E; Gambardella A; De Backer M; Joeres L; Brunnert M; Dedeken P; Serratosa J.
Acta Neurol Scand (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.
Mentis AA; Dardiotis E; Grigoriadis N; Petinaki E; Hadjigeorgiou GM.
Acta Neurol Scand (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
A disease, disorder, illness or condition: How to label epilepsy?
Noble AJ; Robinson A; Marson AG.
Acta Neurol Scand (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Eslicarbazepine acetate as adjunctive therapy in clinical practice: ESLADOBA study.
Chaves J; Breia P; Pimentel J; Pelejão R; Carvalho M; Mateus P; Grebe H; Mestre A; Fernandes H; Sousa R; Gala A.
Acta Neurol Scand (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Parkinson's disease in Germany: prevalence and incidence based on health claims data.
Nerius M; Fink A; Doblhammer G.
Acta Neurol Scand (Unknown)
Published: 2016
1/6 Transparent
Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P.
Acta Neurol Scand (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
The mechanisms of sudden-onset type adverse reactions to oseltamivir.
Hama R; Bennett CL.
Acta Neurol Scand (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Subjective health complaints predict functional outcome six months after stroke.
Hofstad H; Naess H; Gjelsvik BE; Eide GE; Skouen JS.
Acta Neurol Scand (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy.
Holtkamp M; McMurray R; Bagul M; Sousa R; Kockelmann E.
Acta Neurol Scand (Unknown)
Published: 2016
3/6 Transparent
Registered Funding Declared
Variants in the genes DCTN2, DNAH10, LRIG3, and MYO1A are associated with intermediate Charcot-Marie-Tooth disease in a…
Braathen GJ; Høyer H; Busk ØL; Tveten K; Skjelbred CF; Russell MB.
Acta Neurol Scand (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Perampanel for focal epilepsy: insights from early clinical experience.
Trinka E; Steinhoff BJ; Nikanorova M; Brodie MJ.
Acta Neurol Scand (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Long-term efficacy and safety of adjunctive extended-release oxcarbazepine (Oxtellar XR<sup>®</sup> ) in adults with pa…
Chung SS; Johnson JK; Brittain ST; Baroldi P.
Acta Neurol Scand (Unknown)
Published: 2015
3/6 Transparent
Registered Funding Declared
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Grytten N; Torkildsen Ø; Myhr KM.
Acta Neurol Scand (Unknown)
Published: 2015
1/6 Transparent
Age dependency of ischaemic stroke subtypes and vascular risk factors in western Norway: the Bergen Norwegian Stroke Co…
Nacu A; Fromm A; Sand KM; Waje-Andreassen U; Thomassen L; Naess H.
Acta Neurol Scand (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Case-fatality and disability in the Tanzanian Stroke Incidence Project cohort.
Walker RW; Wakefield K; Gray WK; Jusabani A; Swai M; Mugusi F.
Acta Neurol Scand (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Long-term epidemiology of multiple sclerosis in the Northern Seville District.
Izquierdo G; Venegas A; Sanabria C; Navarro G.
Acta Neurol Scand (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory …
French JA; Baroldi P; Brittain ST; Johnson JK; PROSPER Investigators Study Group.
Acta Neurol Scand (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment…
Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD.
Acta Neurol Scand (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Headaches and the N95 face-mask amongst healthcare providers.
Lim EC; Seet RC; Lee KH; Wilder-Smith EP; Chuah BY; Ong BK.
Acta Neurol Scand (Unknown)
Published: 2006
Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis.
Dessau RB; Lisby G; Frederiksen JL.
Acta Neurol Scand (Unknown)
Published: 1999
Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France.
Berr C; Puel J; Clanet M; Ruidavets JB; Mas JL; Alperovitch A.
Acta Neurol Scand (Unknown)
Published: 1989